NeuroSense Therapeutics (NRSN) Times Interest Earned (2021 - 2024)
NeuroSense Therapeutics (NRSN) posted Times Interest Earned of -$0.25 for Q4 2024, up 78.45% sequentially from -$1.15 in Q4 2023, and up 78.45% YoY from -$0.14 in Q1 2024.
NeuroSense Therapeutics (NRSN) Times Interest Earned (2021 - 2024) Analysis & Trends
NeuroSense Therapeutics has reported Times Interest Earned for 4 years, with the latest figure at -$0.25 in Q4 2024.
- Quarterly Times Interest Earned rose 78.45% year-over-year to -$0.25 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was -$1.39 (up 94.84% YoY) and the FY2025 annual result came in at -$1.09, up 21.31% from the prior year.
- Times Interest Earned grew to -$0.25 in Q4 2024 per NRSN's latest filing, from -$1.15 in the prior quarter.
- Over five years, Times Interest Earned peaked at $331.9 in Q3 2022 and troughed at -$79.25 in Q2 2021.
- A 4-year average of $66.2 and a median of $4.76 in 2021 frame the typical range for Times Interest Earned.
- The widest YoY moves for Times Interest Earned: up 229.43% in 2022, down 154.44% in 2022.
- Over 4 years, Times Interest Earned stood at $4.76 in 2021, then plunged by 154.44% to -$2.59 in 2022, then jumped by 55.52% to -$1.15 in 2023, then soared by 78.45% to -$0.25 in 2024.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$0.25, -$1.15, and $218.83 for Q4 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | NeuroSense Therapeutics | 9.68 Mn | 9.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -0.25 |
| Dec 31, 2023 | -1.15 |
| Sep 30, 2023 | 218.83 |
| Jun 30, 2023 | 1.79 |
| Mar 31, 2023 | 9.65 |
| Dec 31, 2022 | -2.59 |
| Sep 30, 2022 | 331.90 |
| Jun 30, 2022 | 102.57 |
| Mar 31, 2022 | 141.91 |
| Dec 31, 2021 | 4.76 |
| Jun 30, 2021 | -79.25 |